Department of Neurology, University of Goettingen, Goettingen, Germany.
Eur J Neurol. 2011 Apr;18(4):547-55. doi: 10.1111/j.1468-1331.2010.03229.x. Epub 2010 Oct 27.
Studies addressing the diagnostic relevance of anti-Borrelia burgdorferi (BB) serum antibodies in patients with non-specific symptoms and suspected chronic Lyme neuroborreliosis (LNB) are scarce.
In this study, we enrolled within 1 year 122 patients with suspected chronic LNB. One hundred and fourteen patients had previously tested positive for BB. All patients had previously received antibiotic treatment. Each patient received a clinical examination and measurement of BB-specific antibodies. The diagnosis of neuroborreliosis was made according to the national guidelines of the German Society of Neurology. Nine patients had acute borreliosis. One of the nine met the criteria of acute LNB. Of the remaining 113 patients, 85 patients underwent a lumbar puncture. Ten seronegative subjects without lumbar puncture were also considered. In 61.8% of these 95 patients the quality of life, of sleep, mood, and anxiety were assessed.
Of 95 patients, 25.3% had symptoms without a somatic cause or evidence of borreliosis, 38.9% had a well-defined illness unrelated to BB infection, and 29.5% suffered from symptoms without a detectable somatic cause, displaying antibodies against BB. Six patients were grouped as post-LNB syndrome. Most common symptoms in all categories were arthralgia, myalgia, dysaesthesia, depressive mood and chronic fatigue.
Patients with persistent symptoms with elevated serum antibodies against BB but without signs of cerebrospinal fluid inflammation require further diagnostic examinations to exclude ongoing infection and to avoid co-infections and other treatable conditions (e.g. autoimmune diseases). One patient with acute LNB, who was treated with ceftriaxone for 3 weeks suffered from LNB with new headaches and persistent symptoms 6 months later. These data should encourage further studies with new experimental parameters.
针对具有非特异性症状和疑似慢性莱姆神经Borreliosis(LNB)的患者,研究抗 Borrelia burgdorferi(BB)血清抗体的诊断相关性的研究很少。
在这项研究中,我们在 1 年内招募了 122 名疑似慢性 LNB 的患者。其中 114 例患者之前检测出 BB 阳性。所有患者均接受过抗生素治疗。每位患者均接受了临床检查和 BB 特异性抗体测量。神经 Borreliosis 的诊断根据德国神经病学学会的国家指南进行。9 例患者患有急性 Borreliosis。其中 1 例符合急性 LNB 的标准。在其余的 113 例患者中,85 例行腰椎穿刺。也考虑了 10 例未行腰椎穿刺的血清阴性患者。在这 95 例患者中,61.8%的患者评估了生活质量、睡眠、情绪和焦虑。
在 95 例患者中,25.3%的患者出现无躯体原因或 Borreliosis 证据的症状,38.9%的患者患有与 BB 感染无关的明确疾病,29.5%的患者患有无明显躯体原因但显示针对 BB 的抗体的症状。6 例患者被归类为 post-LNB 综合征。所有类别中最常见的症状是关节痛、肌痛、感觉异常、抑郁情绪和慢性疲劳。
持续性症状且血清抗 BB 抗体升高但无脑脊液炎症迹象的患者需要进一步的诊断检查以排除持续感染,并避免合并感染和其他可治疗的疾病(例如自身免疫性疾病)。1 例急性 LNB 患者接受头孢曲松治疗 3 周后出现新的头痛和持续性症状,6 个月后再次出现 LNB。这些数据应鼓励进一步研究新的实验参数。